Enog, Hannan .
HRN: 26-78-02 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/04/2025
CEFUROXIME 1.5GM (VIAL)
03/04/2025
03/05/2025
IVT
1.5gms
Q12
S/P CS
Waiting Final Action
03/06/2025
CEFUROXIME 500MG (TAB)
03/06/2025
03/13/2025
PO
500 MG
BID
NKA
Waiting Final Action